Bank of America’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
VCM
VFT
MFG
Bank of America's ANVS Position: Q1 2026 in Review
Bank of America sold out of Annovis Bio (ANVS) in Q1 2026, closing a stake of 207 shares — an estimated $716 sold.
Bank of America first reported a position in ANVS in Q1 2020 and held it in 19 quarters. The position peaked at $555K in Q3 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.
- Bank of America reported no remaining Annovis Bio position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 207 Annovis Bio shares in Q1 2026, an estimated $716.
- Bank of America first reported a position in Annovis Bio in Q1 2020 and held it in 19 quarters.
- Bank of America's Annovis Bio position peaked at $555K in Q3 2021.
- 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.